35.65
price up icon0.17%   0.06
after-market 시간 외 거래: 35.92 0.27 +0.76%
loading
전일 마감가:
$35.59
열려 있는:
$35.785
하루 거래량:
2.34M
Relative Volume:
0.60
시가총액:
$15.02B
수익:
$2.26B
순이익/손실:
$1.09B
주가수익비율:
15.21
EPS:
2.3431
순현금흐름:
$2.70B
1주 성능:
-1.63%
1개월 성능:
+2.27%
6개월 성능:
+17.66%
1년 성능:
+26.69%
1일 변동 폭
Value
$35.51
$35.92
1주일 범위
Value
$35.24
$36.89
52주 변동 폭
Value
$24.05
$36.89

로열티 파마 Stock (RPRX) Company Profile

Name
명칭
Royalty Pharma Plc
Name
전화
(212) 883-0200
Name
주소
110 EAST 59TH STREET, NEW YORK, NY
Name
직원
99
Name
트위터
Name
다음 수익 날짜
2025-02-11
Name
최신 SEC 제출 서류
Name
RPRX's Discussions on Twitter

RPRX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
RPRX
Royalty Pharma Plc
35.65 15.27B 2.26B 1.09B 2.70B 2.3431
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.49 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.53 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.52 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
566.14 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.93 27.29B 3.81B -644.79M -669.77M -6.24

로열티 파마 Stock (RPRX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-05-16 개시 Morgan Stanley Overweight
2024-06-03 다운그레이드 UBS Buy → Neutral
2022-06-14 재개 UBS Buy
2022-05-13 개시 Scotiabank Sector Outperform
2022-04-27 개시 Goldman Buy
2022-04-14 업그레이드 JP Morgan Neutral → Overweight
2022-04-06 재개 Morgan Stanley Overweight
2021-10-29 업그레이드 Citigroup Neutral → Buy
2021-07-30 개시 Tigress Financial Buy
2020-11-09 업그레이드 UBS Neutral → Buy
2020-07-14 개시 Evercore ISI In-line
2020-07-13 개시 BofA Securities Buy
2020-07-13 개시 Citigroup Neutral
2020-07-13 개시 Cowen Outperform
2020-07-13 개시 Goldman Neutral
2020-07-13 개시 JP Morgan Neutral
2020-07-13 개시 Morgan Stanley Equal-Weight
2020-07-13 개시 SunTrust Buy
2020-07-13 개시 UBS Neutral
모두보기

로열티 파마 주식(RPRX)의 최신 뉴스

pulisher
03:45 AM

What drives Royalty Pharma plc stock priceExtraordinary profit generation - Autocar Professional

03:45 AM
pulisher
08:33 AM

Los Angeles Capital Management LLC Grows Holdings in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat

08:33 AM
pulisher
Jul 20, 2025

Royalty Pharma plc Stock Analysis and ForecastConsistent triple returns - Autocar Professional

Jul 20, 2025
pulisher
Jul 20, 2025

Royalty Pharma PLC (NASDAQ:RPRX) Stake Raised by Victory Capital Management Inc. - MarketBeat

Jul 20, 2025
pulisher
Jul 20, 2025

Is Royalty Pharma plc a good long term investmentFree Trend-Following Techniques - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

What analysts say about Royalty Pharma plc stockTriple returns potential - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 20, 2025

Edgestream Partners L.P. Invests $659,000 in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat

Jul 20, 2025
pulisher
Jul 20, 2025

Morgan Stanley Raises Royalty Pharma (RPRX) Price Target, Maintains Overweight Rating - MSN

Jul 20, 2025
pulisher
Jul 20, 2025

Royalty Pharma (NASDAQ:RPRX) Reaches New 52-Week HighTime to Buy? - MarketBeat

Jul 20, 2025
pulisher
Jul 19, 2025

Cullen Frost Bankers Inc. Has $7.72 Million Stock Holdings in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat

Jul 19, 2025
pulisher
Jul 19, 2025

C WorldWide Group Holding A S Makes New Investment in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat

Jul 19, 2025
pulisher
Jul 19, 2025

Royalty Pharma Declares Q3 2025 Dividend of $0.22 per Class A Share - AInvest

Jul 19, 2025
pulisher
Jul 18, 2025

Royalty Pharma Declares Q3 2025 Dividend of $0.22 per Class A Ordinary Share - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Royalty Pharma PLC Announces Quarterly Dividend of $0.22 (NASDAQ:RPRX) - MarketBeat

Jul 18, 2025
pulisher
Jul 18, 2025

Royalty Pharma Declares Third Quarter 2025 Dividend - The Globe and Mail

Jul 18, 2025
pulisher
Jul 18, 2025

Royalty Pharma announces $0.22 per share dividend for Q3 2025 - Investing.com

Jul 18, 2025
pulisher
Jul 18, 2025

Royalty Pharma plc (RPRX) Declares $0.22 Quarterly Dividend; 2.5% Yield - StreetInsider

Jul 18, 2025
pulisher
Jul 18, 2025

Royalty Pharma Announces Q3 2025 Dividend of $0.22 per Share - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

How to Take Advantage of moves in (RPRX) - news.stocktradersdaily.com

Jul 18, 2025
pulisher
Jul 18, 2025

Bryn Mawr Capital Management LLC Boosts Stock Position in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat

Jul 18, 2025
pulisher
Jul 18, 2025

Is Royalty Pharma plc stock a good hedge against inflationHigh Potential Safe Trades - Newser

Jul 18, 2025
pulisher
Jul 17, 2025

Royalty Pharma adds two independent directors to board By Investing.com - Investing.com South Africa

Jul 17, 2025
pulisher
Jul 17, 2025

Royalty Pharma Appoints Carole Ho and Elizabeth Weatherman to the Company’s Board of Directors - The Manila Times

Jul 17, 2025
pulisher
Jul 17, 2025

Royalty Pharma adds two independent directors to board - Investing.com

Jul 17, 2025
pulisher
Jul 17, 2025

Royalty Pharma Appoints Two New Independent Directors, Boosting Independent Board Representation to Over 90% - Quiver Quantitative

Jul 17, 2025
pulisher
Jul 17, 2025

Royalty Pharma Appoints Denali CMO and Warburg Pincus Veteran to Board Following Major Acquisition - Stock Titan

Jul 17, 2025
pulisher
Jul 17, 2025

Strata Wealth Advisors LLC Invests $387,000 in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat

Jul 17, 2025
pulisher
Jul 17, 2025

Cerity Partners LLC Increases Stock Position in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat

Jul 17, 2025
pulisher
Jul 17, 2025

Bank of New York Mellon Corp Has $45.53 Million Stock Holdings in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat

Jul 17, 2025
pulisher
Jul 16, 2025

Royalty Pharma to Announce Second Quarter 2025 Financial Results on August 6, 2025 - The Manila Times

Jul 16, 2025
pulisher
Jul 15, 2025

Why Royalty Pharma plc stock attracts strong analyst attentionDaily Swing Candidates - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Royalty Pharma plc stock performs during market volatilityMarket Timing Advice - beatles.ru

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Royalty Pharma plc stock price move sharplyFree Trading Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

M&T Bank Corp Increases Stock Position in Royalty Pharma PLC (NASDAQ:RPRX) - Defense World

Jul 15, 2025
pulisher
Jul 14, 2025

Fiera Capital Announces the Termination of imaxx Canadian Fixed Pay Fund and of imaxx Short Term Bond Fund - The Globe and Mail

Jul 14, 2025
pulisher
Jul 14, 2025

Bank of New York Mellon Corp Has $45.53 Million Stake in Royalty Pharma PLC (NASDAQ:RPRX) - Defense World

Jul 14, 2025
pulisher
Jul 14, 2025

Rehmann Capital Advisory Group Purchases Shares of 17,649 Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat

Jul 14, 2025
pulisher
Jul 13, 2025

D.A. Davidson & CO. Trims Position in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat

Jul 13, 2025
pulisher
Jul 13, 2025

Royalty Pharma (NASDAQ:RPRX) Hits New 1-Year HighTime to Buy? - MarketBeat

Jul 13, 2025
pulisher
Jul 12, 2025

Teacher Retirement System of Texas Sells 12,028 Shares of Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat

Jul 12, 2025
pulisher
Jul 11, 2025

Royalty Pharma stock hits 52-week high at 36.44 USD By Investing.com - Investing.com South Africa

Jul 11, 2025
pulisher
Jul 11, 2025

Royalty Pharma PLC (NASDAQ:RPRX) Stake Lessened by China Universal Asset Management Co. Ltd. - MarketBeat

Jul 11, 2025
pulisher
Jul 10, 2025

Royalty Pharma stock hits 52-week high at 36.44 USD - Investing.com

Jul 10, 2025

로열티 파마 (RPRX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$21.69
price down icon 0.87%
$102.78
price up icon 0.22%
$26.34
price up icon 0.53%
$108.91
price down icon 1.01%
biotechnology ONC
$291.93
price down icon 0.89%
자본화:     |  볼륨(24시간):